跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,548 条关于
“Silence Therapeutics plc”
全部
21,548
临床试验
5,507
药物
3,718
机构
2,947
资讯
9,376
3个月前
Silence Therapeutics Reports Positive Phase II Zerlasiran Data and Phase I Divesiran Results, Extends Cash Runway into 2027
11个月前
Silence Therapeutics Completes Enrollment in Phase 2 Trial of First-in-Class siRNA for Polycythemia Vera
上个月
Novel Hypercholesterolemia Drugs Market to Reach USD 42.8 Billion by 2036 as Oral PCSK9 Inhibition and Gene Editing Expand Treatment Options
18天前
ANGPTL3 Inhibitors Market Poised to Reach $3.48 Billion by 2035 as Pipeline Diversifies Beyond Monoclonal Antibodies
去年
Zerlasiran Shows Promise in Reducing Lipoprotein(a) in Phase 2 Trial
去年
Silence Therapeutics Halts Phase III Development of Zerlasiran, Seeks Partnership for Cardiovascular Drug
去年
Iterum Therapeutics' Orlynvah Receives FDA Approval for Uncomplicated UTIs
去年
Silence Therapeutics Reports Promising Phase 1 Data for Divesiran in Polycythemia Vera at EHA 2025
3年前
hVIVO PLC Develops hMPV Human Challenge Model
去年
hVIVO Completes Pilot Study for Human Metapneumovirus (hMPV) Challenge Model
第 1 页,共 938 页
上一页
下一页